These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 3358887)

  • 1. Inhibition of the enzyme, GABA-aminotransferase in human platelets by vigabatrin, a potential antiepileptic drug.
    Rimmer E; Kongola G; Richens A
    Br J Clin Pharmacol; 1988 Feb; 25(2):251-9. PubMed ID: 3358887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between platelet and brain GABA transaminase inhibition by single and multiple doses of vigabatrin in rats.
    Valdizán EM; Armijo JA
    Epilepsia; 1991; 32(5):735-42. PubMed ID: 1915185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of vigabatrin on brain and platelet GABA-transaminase activities.
    Bolton JB; Rimmer E; Williams J; Richens A
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):35S-42S. PubMed ID: 2757907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma-vinyl GABA (vigabatrin): relationship between dosage, plasma concentrations, platelet GABA-transaminase inhibition, and seizure reduction in epileptic children.
    Arteaga R; Herranz JL; Valdizán EM; Armijo JA
    Epilepsia; 1992; 33(5):923-31. PubMed ID: 1396437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of vigabatrin.
    Sabers A; Gram L
    Pharmacol Toxicol; 1992 Apr; 70(4):237-43. PubMed ID: 1608908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time course of the GABAergic effects of vigabatrin: is the time course of brain GABA related to platelet GABA-transaminase inhibition?
    Valdizán EM; García AP; Armijo JA
    Epilepsia; 1999 Aug; 40(8):1062-9. PubMed ID: 10448817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma-vinyl GABA: a new antiepileptic drug.
    Hammond EJ; Wilder BJ
    Clin Neuropharmacol; 1985; 8(1):1-12. PubMed ID: 3884148
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical pharmacology of vigabatrin.
    Schechter PJ
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):19S-22S. PubMed ID: 2667604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind study of gamma-vinyl GABA in patients with refractory epilepsy.
    Rimmer EM; Richens A
    Lancet; 1984 Jan; 1(8370):189-90. PubMed ID: 6141335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of single and multiple increasing doses of vigabatrin on brain GABA metabolism and correlation with vigabatrin plasma concentration.
    Valdizán EM; Armijo JA
    Biochem Pharmacol; 1992 May; 43(10):2143-50. PubMed ID: 1599502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental studies of the influence of vigabatrin on the GABA system.
    Gram L; Larsson OM; Johnsen A; Schousboe A
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):13S-17S. PubMed ID: 2757904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coadministration of vigabatrin and valproate in children with refractory epilepsy.
    Armijo JA; Arteaga R; Valdizán EM; Herranz JL
    Clin Neuropharmacol; 1992 Dec; 15(6):459-69. PubMed ID: 1477847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychophysiological and psychometric studies after manipulating the GABA system by vigabatrin, a GABA-transaminase inhibitor.
    Saletu B; Grünberger J; Linzmayer L; Schwartz JJ; Haegele KD; Schechter PJ
    Int J Psychophysiol; 1986 May; 4(1):63-80. PubMed ID: 3721943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic toxicity studies with vigabatrin, a GABA-transaminase inhibitor.
    Gibson JP; Yarrington JT; Loudy DE; Gerbig CG; Hurst GH; Newberne JW
    Toxicol Pathol; 1990; 18(2):225-38. PubMed ID: 2399411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of gamma-vinyl GABA on bicuculline-induced seizures.
    Kendall DA; Fox DA; Enna SJ
    Neuropharmacology; 1981 Apr; 20(4):351-5. PubMed ID: 7290349
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental studies and controlled clinical testing of valproate and vigabatrin.
    Gram L
    Acta Neurol Scand; 1988 Oct; 78(4):241-70. PubMed ID: 3146860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of vigabatrin, gamma-acetylenic GABA, aminooxyacetic acid, and valproate on levels of various amino acids in rat brain regions and plasma.
    Löscher W; Hörstermann D
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Mar; 349(3):270-8. PubMed ID: 8208305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gabapentin potentiation of the antiepileptic efficacy of vigabatrin in an in vitro model of epilepsy.
    Lücke A; Musshoff U; Köhling R; Osterfeld M; Mayer T; Wolf P; Schütte W; Speckmann EJ
    Br J Pharmacol; 1998 May; 124(2):370-6. PubMed ID: 9641555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of tolerance to the anticonvulsant effect of vigabatrin in amygdala-kindled rats.
    Rundfeldt C; Löscher W
    Eur J Pharmacol; 1992 Mar; 213(3):351-66. PubMed ID: 1618278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of increasing doses of vigabatrin on platelet gamma-aminobutyric acid-transaminase and brain gamma-aminobutyric acid in rats.
    Valdizán EM; García AP; Armijo JA
    Eur J Pharmacol; 1999 Mar; 369(2):169-73. PubMed ID: 10206175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.